Immunopharmacological evaluation of adjuvant efficacy of Monophosphoryl lipid-A and CpG ODN with SARS-CoV-2 RBD antigen
S. Sambyal, V. Sravanthi, R. Khatri, G. Siddiqui, S. Ahmed, S. Samal, H. M. Sampath Kumar
The paper evaluates the immunopharmacological efficacy of MPL-A and CpG ODN adjuvants with SARS-CoV-2 RBD antigen, showing they elicit potent antibody responses and enhance T and B cell populations.
bioRxiv · Apr 4, 2022 · PreprintImmunology